58168-12-0Relevant articles and documents
A novel piperine analogue exerts in vivo antitumor effect by inducing oxidative, antiangiogenic and immunomodulatory actions
Abrantes, Renata Albuquerque de,Athayde-Filho, Petr?nio Filgueiras de,Batista, Tatianne Mota,Brand?o, Maria Cláudia Rodrigues,Cavalcanti, Raquel Fragoso Pereira,Duarte, Samia Sousa,Farias, Davi Felipe,Ferreira, Rafael Carlos,Leite, Fagner Carvalho,Lisboa, Thaís Mangeon Honorato,Mangueira, Vivianne Mendes,Medeiros, Karina Carla de Paula,Silva, Daiana Karla Frade,Sobral, Marianna Vieira,Sousa, Tatyanna Kélvia Gomes de,Trindade, Emmely Oliveira da
, (2020/05/25)
Structural diversity characterizes natural products as prototypes for design of lead compounds. The aim of this study was to synthetize, and to evaluate the toxicity and antitumor action of a new piperine analogue, the butyl 4-(4-nitrobenzoate)-piperinoat
QUINONE BASED NITRIC OXIDE DONATING COMPOUNDS FOR OPHTHALMIC USE
-
Page/Page column 38-39, (2014/11/11)
The present invention relates to nitric oxide donor compounds having a quinone based structure of formula (I), wherein R1 to R6, n, m and p are as defined in claim 1, compositions thereof and said compounds for use in the treatment and/or prophylaxis of glaucoma and ocular hypertension.
QUINONE BASED NITRIC OXIDE DONATING COMPOUNDS
-
Page/Page column 24, (2014/11/11)
The present invention relates to nitric oxide donor compounds having a quinone based structure, to processes for their preparation and to their use in the treatment of pathological conditions where a deficit of NO plays an important role in their pathogen